| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Būtiski notikumi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2010-03-10 11:20:38 |
| Versijas komentārs | |
| Teksts |
“Olainfarm” plans to maintain the sales growth and to
open a representative office in Bangkok
In 2010 JSC „Olainfarm” plans to maintain the level of
sales growth achieved in 2009 and to earn higher profits than
previous year. In 2009 net profit of Olainfarm was 2.56
million lats (3.64 million euros), while the sales reached 22.4
million lats (32 million euros). The company intends
to expand its operations in the markets of Central Asia and to open
a representative office in Bangkok.
Unaudited profit and loss statement of Olainfarm for
2009 shows that the sales of Concern reached 22.4 million lats (32
million euros). Net profit of the Concern during
this period was 2 560 492 lats (3 643
251euros), while in 2008 the Concern made
a loss of 1 436 905 lats (2
044 532 euros).
During 2009 the sales grew particularly strongly in
markets where particularly strong marketing effort was
made. Sales to Russia grew by 33%, to Belarus by 10%,
Kazakhstan and Azerbaijan both grew by 65%. Ukraine has become
the second biggest market for the company as about 14% of company’s
sales were made there.
During 2009 45 new registrations in 13 different
countries have been approved. Registrations have taken place
in some countries that have so far been rather exotic for company’s
sales, including Tajikistan, Turkmenistan, Poland, Albania and
Australia. Registration processes have also been launched in
Romania and Vietnam. Products that are being
registered include totally new names for the company, like
meldonium, olanzapine, amlodipine, flukonazole, terbinafine and
memantine. Good Manufacturing Practice certificate for
production of 2 new active substances has also been obtained in
2009.
AS „Olainfarm“ is one of the largest companies in
Baltic countries with nearly 40 years of experience in production
of medicines and chemical and pharmaceutical products. The key
principle of company’s operations is to produce reliable and
effective top quality products for Latvia and the rest of the
world. Currently products of “Olainfarm” are being exported to
more than 30 countries worldwide, including the Baltics, Russia,
other CIS, Europe, North America, Asia, Australia
Information prepared by
Salvis Lapins
JSC "Olainfarm"
Member of the Board
tel. +371 6 7013717,
cell: + 371 2 6448873
fax. + 371 6 7013777
|
| Pielikumi |
|